Premature ovarian failure and dehydroepiandrosterone

Mamas L, Mamas E

doi:10.1016/j.fertnstert.2007.11.055

Premature ovarian failure and dehydroepiandrosterone

Mamas L et al., 2008

Fertility and Sterility, 91(2), 644-646

DOI 10.1016/j.fertnstert.2007.11.055

Abstract

In the light of similarities between premenstrual syndrome and toxaemia, and the fact that treatment of the former with progesterone not only relieved the symptoms (Greene and Dalton, 1953) but also prevented the development of edema, hypertension, and albumin

Topics

Infertility > Female Factor > Age-Related Reproductive Endocrinology > AMH > Ovarian Reserve Reproductive Endocrinology > Ovulation > Induction

dhea premature ovarian failure treatment, dehydroepiandrosterone poi supplementation, ovarian insufficiency dhea therapy, premature menopause dhea protocol, diminished ovarian reserve dhea, poi hormone supplementation outcomes, dhea infertility treatment pilot study, early ovarian failure hormone therapy, dhea ovarian function restoration, premature ovarian insufficiency treatment options

Cite this article

Mamas, L., & Mamas, E. (2008). Premature ovarian failure and dehydroepiandrosterone. *Fertility and sterility*, *91*(2), 644-646. https://doi.org/10.1016/j.fertnstert.2007.11.055

Keywords

Adult, Dehydroepiandrosterone/therapeutic Use, Estradiol/blood, Female, Fertility Agents, Female/therapeutic Use, Follicle Stimulating Hormone, Human/blood, Humans, Infertility, Female/blood/drug Therapy/etiology, Luteinizing Hormone/blood, Pilot Projects, Pregnancy, Pregnancy Rate, Primary Ovarian Insufficiency/blood/complications/drug Therapy, Treatment Outcome, Fertility Agents, Female, Follicle Stimulating Hormone, Human, Dehydroepiandrosterone, Estradiol, Luteinizing Hormone,

Premature ovarian failure and dehydroepiandrosterone

Abstract

Topics

Cite this article

Keywords

Related articles

A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment

Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization

Clomiphene citrate with intrauterine insemination: is it effective therapy in women above the age of 35 years?

Lower anti-Müllerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women